Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

6 min ago |

Wednesday's ETF with Unusual Volume: PPH

The Pharmaceutical ETF is seeing unusually high volume in afternoon trading Wednesday, with over 377,000 shares traded versus three month average volume of about 101,000.


Related Topix: Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Financial Markets

1 hr ago | Barron's

Puma Biotechnolgy Triples on Trial Data, Still Room to Run?

Although we did not see a positive neratinib ExteNET outcome in adjuvant breast cancer as a complete surprise, we believe the magnitude of benefit is among best-case scenarios that could be envisioned.


Related Topix: Healthcare Law, Law, Medicine, Breast Cancer, Biotech, Healthcare Industry

1 hr ago | BioSpace

Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials

July 23, 2014 By Renee Morad , Breaking News Staff Puma Biotechnology Inc. announced an amendment to its licensing agreement with Pfizer regarding its investigational cancer drug neratinib, or PB272.


Related Topix: Biotech, Medicine, Healthcare Industry, Startups,, Media, Fox Filmed Entertainment

3 hrs ago |

Pfizer: A Fairly Valued Stock

In a previous article we saw that Pfizer Inc. was the principal holding in Zacks Investment ManagementA s Portfolio.


Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 22, 2014


UPDATE 1-Puma says cancer drug meets trial goal, shares soar

Shares of the company, which doesn't have any drug in the market, tripled to $176.94 in extended trading.


Related Topix: Medicine, Health, Breast Cancer, Biotech, Healthcare Industry, Lung Cancer

Fox News

FT: 25 More Firms May Seek Tax Breaks Overseas

A top Democrat warned on Tuesday a recent string of so-called tax inversions could foreshadow future moves as U.S. firms look to dodge American taxes.


Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech, Business News

No Need To Envy Tax-Inversion Takeovers: Better Tax Deal Awaits

Watching big pharmaceutical companies and other major U.S. corporations line up to make foreign acquisitions that will bring them a low-tax haven as headquarters, a middle market CEO/owner/entrepreneur could easily become jealous.


Related Topix: Walgreens, Retail, Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech

Pfizer Given Average Rating of "Buy" by Analysts

Shares of Pfizer have received a consensus rating of "Buy" from the seventeen ratings firms that are covering the company, Stock Ratings Network reports .


Related Topix: Biotech, Medicine, Healthcare Industry, Investment Banking, Financial Services, Jefferies Group, Investment Services

Mon Jul 21, 2014


Dow Analyst Moves: PFE

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Pfizer is the #16 analyst pick.


Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Business News, Video

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .


Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

Although This Hedge Fund Changed Stocks in Three of Them Bet More

Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission .


Related Topix: Corporate / Securities Law, Law, Securities and Exchange Commission, Biotech, Medicine, Healthcare Industry, Exxon Mobil, Oil & Gas, Energy, Chevron Corporation, Banking, Wells Fargo , Financial Services, Mortgage, Personal Finance

Fri Jul 18, 2014

The Independent

US drugs giant finally seals A 32bn takeover of Shire

Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.


Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

Judge finds Pfizer responsible for $1.72M in sewer payments

The Borough of West Chester early this week won the latest episode in a years-long court battle with drugmaker Pfizer over sewer payments owed to the borough by Wyeth, the pharmaceutical company that Pfizer bought in 2009 for $68 billion.


Related Topix: Biotech, Medicine, Healthcare Industry, West Chester, PA

Fox News

Will Congress Scuttle the AbbVie-Shire Merger?

AbbVie's $54 billion proposal to acquire Irish drug maker Shire would mark the largest tax inversion ever, as a growing number of U.S. companies pursue lower rates overseas.


Related Topix: US News, Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Abbott Laboratories, Medtronic, Medical Equipment, Orrin Hatch, US Senate, Republican, US Politics

Thu Jul 17, 2014

Value Line

Drug Roundup - July 17, 2014

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.


Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Eli Lilly, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Pharmaceuticals


Bristol-Myers Squibb Company And Pfizer Inc. Announce Enrollment Of...

Bristol-Myers Squibb Company And Pfizer Inc. Announce Enrollment Of First Patient In Phase IV EMANATE Trial To Assess Effectiveness And Safety Of Eliquis In Patients With NVAF Undergoing Cardioversion PRINCETON, N.J. & NEW YORK-- --Bristol-Myers Squibb Company and Pfizer Inc. today announced that the first patient has been enrolled into a Phase IV ... (more)


Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Princeton, NJ, Bloomsbury Publishing, Publishing, Media, Medarex, Excaliard Pharmaceuticals

XLV, RZG: Big ETF Outflows

Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the Health Care Select Sector SPDR Fund , where 4,800,000 units were destroyed, or a 3.0% decrease week over week.


Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Financial Markets

Seeking Alpha

Positive top-line results for BeneFIX

In a Phase 3 clinical tria l comparing Pfizer's BeneFIX Coagulation Factor IX as a treatment for patients with moderately severe-to-severe hemophilia B to on-demand treatment, the once-weekly therapy achieved its primary endpoint of a statistically significant reduction in the annualized bleeding rate versus on-demand.


Related Topix: Biotech, Medicine, Healthcare Industry, Hemophilia, Health

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Net income for the quarter ended June 30, 2014 was $3,873,000 or $1.82 ... )--ISIN XS0179021133 Issuer Name GREENLAND CDO LTD Paying Agent HSBC BANK PLC Redemption Type REPURCHASE Currency EUR O/S Balance 244,020,000.00 New Balance 0 .0... )--FUND A db x-trackers MSCI JAPAN TRN INDEX UCITS ETF DEALING DATE A 15-Jul-14 NAV PER SHARE A USD47.7014 ... (more)


Related Topix: RiskMetrics, MSCI, Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex

Seeking Alpha

Xalkori: Pfizer's Lung Cancer Drug Might Get A Future Boost In Sales

It is no secret that Pfizer has had a rocky first half this year. The difficulties around its attempt to acquire AstraZeneca were compounded by Q1 sales that missed market expectations by 9 percent.


Related Topix: Medicine, Cancer, Health, Lung Cancer, Biotech, Healthcare Industry, AstraZeneca, AstraZeneca Group, Oncology


Ashburn Jobs